Loading...

Jeffrey Loh-Doyle

Title(s)Assistant Professor of Clinical Urology
SchoolKeck School of Medicine of USC
vCardDownload vCard

    Collapse Biography 
    Collapse Education and Training
    University of Southern California , Los Angeles B.A. Biological Sciences, Minor in International Relations 05/2007
    Keck School of Medicine of USC , Los Angeles M.D. 5/2011
    LAC+USC, Los Angeles Internship 6/2012General Surgery/Urology
    LAC+USC, Los Angeles Residency 6/2016Urology
    USC Institute of Urology, Los Angeles Fellow 6/2017Genitourinary Reconstruction and Prosthetics
    LAC+USC , Los Angeles 06/2017Healthcare Administration Scholar

    Collapse Overview 
    Collapse Overview
    Jeffrey Loh-Doyle, MD, is a specialist in complex surgical reconstruction of the male urinary tract, male urinary incontinence, erectile dysfunction, sexual health, urethral stricture disease, and Peyronie’s Disease. He joins the USC Institute of Urology after completing his urology residency at USC and further fellowship training in male genitourinary reconstructive and prosthetic surgery under Dr. Stuart Boyd, a world-renown reconstructive cancer surgeon and authority on reconstruction of the lower urinary tract and urologic prosthestics.

    Born and raised in Los Angeles, Dr. Loh-Doyle completed his undergraduate and medical school education in the prestigious Baccalaureate/MD program at the Keck School of Medicine of USC, where he achieved degrees in biological sciences, international relations, and doctor of medicine. Dr. Loh-Doyle’s areas of clinical and research interest include erectile dysfunction, male urinary incontinence, Peyronie’s Disease, reconstruction of the urinary tract, and urologic oncology. In addition to urology, he also has a keen interest in health policy and quality improvement and participated in a two-year health care administration scholars program run by the Los Angeles County Department of Health. He was awarded a grant to improve the peri-operative patient experience at Los Angeles County+USC, and he is an active participant in several committees aimed at improving the delivery of sophisticated healthcare to the underserved.

    Collapse Research 
    Collapse Research Activities and Funding
    Bladder Cancer Survivorship
    Aug 1, 2017
    Role: Principal Invesitgator
    Inflatable Penile Prosthesis: Technical Considerations and Long-Term Outcomes

    Role: Principal Investigator
    Artificial Urinary Sphincter Technique and Long-Term Outcomes

    Role: Principal Investigator

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
    List All   |   Timeline
    1. Loh-Doyle JC. Penile Implant Considerations in the Bladder Cancer Survivor. Curr Urol Rep. 2019 Jan 28; 20(2):7. PMID: 30689132.
      View in: PubMed
    2. Loh-Doyle JC, Ashrafi A, Nazemi A, Ghodoussipour S, Thompson E, Wayne K, Boyd SD. Dual Prosthetic Implantation After Radical Cystoprostatectomy and Neobladder: Outcomes of the Inflatable Penile Prosthesis and Artificial Urinary Sphincter in Bladder Cancer Survivors. Urology. 2019 Jan 18. PMID: 30664894.
      View in: PubMed
    3. Loh-Doyle JC, Hartman N, Nazemi A, Wayne K, Doumanian LR, Ginsberg DA, Boyd SD. Mechanical failure rates of artificial urinary sphincter components: Is the 3.5-cm urethral cuff at higher risk? Neurourol Urodyn. 2019 Jan; 38(1):187-192. PMID: 30248180.
      View in: PubMed
    4. Loh-Doyle J. Editorial Comment. J Urol. 2018 Aug; 200(2):455. PMID: 29778581.
      View in: PubMed
    5. Loh-Doyle J, Patil MB, Nakhoda Z, Nassiri N, Yip W, Wayne K, Doumanian L, Boyd SD. Three-Piece Inflatable Penile Prosthesis Placement Following Pelvic Radiation: Technical Considerations and Contemporary Outcomes. J Sex Med. 2018 Jul; 15(7):1049-1054. PMID: 29731428.
      View in: PubMed
    6. Lifton J, Ghodoussipour S, Xiao GQ, Dorff T, Loh-Doyle J, Boyd SD. Paratesticular Serous Papillary Carcinoma of High Grade and Malignant Potential: A Rare Case with a Role for Adjuvant Therapy. Cureus. 2018 Feb 13; 10(2):e2188. PMID: 29662727.
      View in: PubMed
    7. Loh-Doyle J, Patil MB, Sawkar H, Wayne K, Boyd SD. 3-Piece Inflatable Penile Prosthesis Placement Following Radical Cystoprostatectomy and Urinary Diversion: Technique and Outcomes. J Sex Med. 2018 Jun; 15(6):907-913. PMID: 29452979.
      View in: PubMed
    8. Clifford TG, Burg ML, Hu B, Loh-Doyle J, Hugen CM, Cai J, Djaladat H, Wayne K, Daneshmand S. Satisfaction With Testicular Prosthesis After Radical Orchiectomy. Urology. 2018 Apr; 114:128-132. PMID: 29288790.
      View in: PubMed
    9. Ghodoussipour SB, Gould D, Lifton J, Badash I, Krug A, Miranda G, Loh-Doyle J, Carey J, Djaladat H, Doumanian L, Ginsberg D. Surviving Fournier's gangrene: Multivariable analysis and a novel scoring system to predict length of stay. J Plast Reconstr Aesthet Surg. 2018 May; 71(5):712-718. PMID: 29284566.
      View in: PubMed
    10. DeLay KJ, Haney NM, Chiang J, Stewart C, Yafi FA, Angermeier K, Wood H, Boone T, Kavanagh AG, Gretzer M, Boyd S, Loh-Doyle JC, Hellstrom WJG. Comparison of Adjuvant Radiation Therapy Before or After Artificial Urinary Sphincter Placement: A Multi-Institutional, Retrospective Analysis. Urology. 2018 03; 113:160-165. PMID: 29223493.
      View in: PubMed
    11. Loh-Doyle J, Bhanvadia S, Patil MB, Djaladat H, Daneshmand S. Vena Cavoscopy in the Assessment of Intraluminal Vena Caval Tumor Involvement. Urology. 2018 Mar; 113:105-109. PMID: 29191641.
      View in: PubMed
    12. Loh-Doyle J. Editorial Comment. J Urol. 2018 Feb; 199(2):574-575. PMID: 29154760.
      View in: PubMed
    13. Loh-Doyle JC, Low RK, Monga M, Nguyen MM. Patient experiences and preferences with ureteral stent removal. J Endourol. 2015 Jan; 29(1):35-40. PMID: 25019375; PMCID: PMC4287107.
    14. Patil MB, Montez J, Loh-Doyle J, Cai J, Skinner EC, Schuckman A, Thangathurai D, Skinner DG, Daneshmand S. Level III-IV inferior vena caval thrombectomy without cardiopulmonary bypass: long-term experience with intrapericardial control. J Urol. 2014 Sep; 192(3):682-8. PMID: 24704114.
      View in: PubMed
    15. Loh-Doyle JC, Patil MB, Daneshmand S. Renal cell carcinoma with inferior vena cava tumor thrombus and metastatic caval wall invasion. Urology. 2012 Feb; 79(2):e6-8. PMID: 21724242.
      View in: PubMed